<div id="readability-page-1"><p>Molina Healthcare (NYSE:MOH - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported $2.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.16 by $0.19, FiscalAI reports. Molina Healthcare had a return on equity of 13.60% and a net margin of 1.04%.The firm had revenue of $10.80 billion during the quarter, compared to the consensus estimate of $10.91 billion.</p><div><p><span></span><span>Get <strong>Molina Healthcare</strong> alerts:</span></p></div><h2>Molina Healthcare Trading Up 1.3%</h2><ul><li>3 Sectors to Buy While They're Down and 1 to Walk Away From</li></ul><p>Molina Healthcare stock traded up $2.03 during mid-day trading on Wednesday, hitting $153.03. The stock had a trading volume of 2,588,255 shares, compared to its average volume of 1,757,444. The stock has a 50-day simple moving average of $143.54 and a two-hundred day simple moving average of $159.39. The stock has a market capitalization of $7.97 billion, a PE ratio of 17.88 and a beta of 0.55. Molina Healthcare has a 12 month low of $121.06 and a 12 month high of $333.22. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.97. </p><h2>Analyst Ratings Changes</h2><p>MOH has been the subject of several research analyst reports. UBS Group  set a $173.00 price objective on Molina Healthcare in a research report on Friday, March 13th. Deutsche Bank Aktiengesellschaft  set a $310.00 price objective on Molina Healthcare in a research report on Friday, March 13th. Truist Financial cut their price objective on Molina Healthcare from $190.00 to $145.00 and set a &#34;hold&#34; rating for the company in a research report on Tuesday, February 17th. TD Cowen cut their price objective on Molina Healthcare from $175.00 to $144.00 and set a &#34;hold&#34; rating for the company in a research report on Monday, February 9th. Finally, The Goldman Sachs Group cut their price objective on Molina Healthcare from $167.00 to $124.00 and set a &#34;neutral&#34; rating for the company in a research report on Wednesday, February 11th. Two investment analysts have rated the stock with a Buy rating, ten have issued  a Hold rating and two have issued  a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of &#34;Hold&#34; and an average target price of $169.21.</p><ul><li>Why Centene Stock Dropped 40% — And Whether It's a Buy Now</li></ul><p><b>View Our Latest Report on MOH</b></p><h2>Hedge Funds Weigh In On Molina Healthcare</h2><p>Several hedge funds have recently added to or reduced their stakes in MOH. Quarry LP bought a new position in  Molina Healthcare in the fourth quarter valued at about $32,000.  Triumph Capital Management boosted its holdings in  Molina Healthcare by 4,625.0% in the fourth quarter. Triumph Capital Management now owns 189 shares of the company's stock valued at $33,000 after acquiring an additional 185 shares during the last quarter.  Brown Brothers Harriman &amp; Co. boosted its holdings in  Molina Healthcare by 96.1% in the fourth quarter. Brown Brothers Harriman &amp; Co. now owns 249 shares of the company's stock valued at $43,000 after acquiring an additional 122 shares during the last quarter.  MUFG Securities EMEA plc bought a new position in  Molina Healthcare in the second quarter valued at about $48,000.  Finally, DV Equities LLC bought a new position in  Molina Healthcare in the fourth quarter valued at about $76,000. Institutional investors own  98.50% of the company's stock. </p><h2>Molina Healthcare Company Profile</h2> (Get Free Report)<ul><li>3 Health Insurance Stocks Holding Green in Market Turmoil</li></ul><p>Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.  </p><p>The company traces its roots to the early 1980s, when Dr.</p><h2>See Also</h2><ul><li>Five stocks we like better than Molina Healthcare</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1PSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1PSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Molina Healthcare Right Now?</h2><p>Before you consider Molina Healthcare, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.</p><p>While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

CURE

RSPH

SPXV

<p>Molina Healthcare (NYSE:MOH) reported quarterly earnings of $2.35 EPS, exceeding analysts' expectations of $2.16. The company generated $10.80 billion in revenue, slightly below the forecast of $10.91 billion. Molina's return on equity was 13.60% with a net margin of 1.04%. The stock rose 1.3% to $153.03, with a market cap of $7.97 billion. Analysts have mixed ratings, with an average target price of $169.21. Institutional investors hold 98.50% of the stock, which specializes in government-sponsored health insurance programs.</p>

Molina Healthcare (NYSE:MOH) Announces Quarterly Earnings Results